← Leaderboards
Yongcheng Song
Baylor College Of Medicine
$4,699,346
Attributed
$4,699,346
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $460.5K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,699,346 · 5
By mechanism
R01$3,418,934 · 2
R21$1,280,412 · 3
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Mariella De Biasi$9,802,698
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsDesignBiologicalComplexToxic EffectStructure-Activity RelationshipProteinsCellsPharmaceutical ChemistryRoentgen RaysDrug KineticsSmall MoleculeInhibitor/AntagonistLeadBiochemicalIn VivoCytotoxicityX-Ray CrystallographyCofactorMouse ModelBiological TestingApoptosisNormal CellEnzymes
Grant awards (14)
Novel Small-Molecule Probes Targeting Oncogenic Fusion MLL in Pediatric Leukemia$437,571
R01 · FY2025 · CA · contact PI
Novel Small-Molecule Probes Targeting Oncogenic Fusion MLL in Pediatric Leukemia$415,694
R01 · FY2024 · CA · contact PI
Novel Small-Molecule Probes Targeting Oncogenic Fusion MLL in Pediatric Leukemia$428,820
R01 · FY2023 · CA · contact PI
Novel Small-Molecule Probes Targeting Oncogenic Fusion MLL in Pediatric Leukemia$437,571
R01 · FY2022 · CA · contact PI
Novel small-molecule inhibitors of SARS-CoV-2 protease$440,000
R21 · FY2021 · AI · contact PI
Chemical Probes Targeting Gliomas with IDH Mutation$342,966
R01 · FY2016 · NS · contact PI
Chemical Probes Targeting Gliomas with IDH Mutation$342,954
R01 · FY2015 · NS · contact PI
Chemical Probes Targeting Gliomas with IDH Mutation$339,511
R01 · FY2014 · NS · contact PI
Chemical Probes Targeting Gliomas with IDH Mutation$330,928
R01 · FY2013 · NS · contact PI
Chemical Probes Targeting Gliomas with IDH Mutation$342,919
R01 · FY2012 · NS · contact PI
Novel inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR)$189,956
R21 · FY2011 · AI · contact PI
Novel Metallo-beta-lactamase Inhibitors$189,956
R21 · FY2011 · AI · contact PI
Novel Metallo-beta-lactamase Inhibitors$230,250
R21 · FY2010 · AI · contact PI
Novel inhibitors of 1-deoxy-D-xylulose-5-phosphate reductoisomerase (DXR)$230,250
R21 · FY2010 · AI · contact PI